| answer text |
<p>Departmental officials regularly discuss a range of issues with the National Institute
for Health and Care Excellence (NICE), including the ongoing methods and process review.</p><p>NICE
recommends the vast majority of medicines it appraises. It has consulted on proposed
changes to its methods and processes which will ensure it retains global leadership
in the evaluation of new medicines and technologies and provides more equitable access
for patients with severe diseases. NICE has undertaken analysis of the impact of its
proposed methods in developing the proposals.</p><p>NICE is proposing a number of
changes to ensure its methods and process are fairer, more consistent and accelerate
the introduction of emerging new types of technology. This will support the Life Sciences
Vision’s commitment to make the United Kingdom the best place in the world to develop,
trial, launch and adopt innovative new medicines, improving patient access to medicines.</p>
|
 |
